Recent Finacing
Recent Raise
Remepy develops patent‑pending "digital molecules"—non‑invasive sensory-based cognitive and behavioral interventions that modulate brain connectivity and immune biomarkers to augment drug+digital therapies for neurodegenerative, cancer, autoimmune, and ocular diseases.
